QT Imaging Holdings Inc

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

QT Imaging Holdings, Inc. is a medical device company, which engages in the research, development, and commercialization of body imaging systems using low energy sound. The company was founded by Avi S. Katz and Raluca Dinu and is headquartered in Novato, CA.

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce expansion of locations offering the Breast Acoustic CTTM Scanner to Couri Center for Gynecology and Integrative Women's Health, in Peoria, IL. The shipment was made together with our strategic business and distribution partner, NXC Imaging, Inc. "Our partnership with QTI marks a pivotal.

QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation at the Radiological Society of North America 2024 Annual Meeting, taking place in Chicago, December 1-5, 2024. Dr. Bilal Malik, Chief Science Officer, Dr. James Wiskin, Fellow, and Dr. Raluca Dinu, Chief Executive Officer, will represent QTI at the event. Dr. Bilal Malik w.

QT Imaging Holdings to Attend Radiological Society of North America 2024 Annual Meeting

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the third quarter of 2024. “During this quarter, QT Imaging's team successfully completed the engineering and clinical feasibility study with our strategic partner and shipped two QT Breast Acoustic CT™ Scanners to a nationally recognized.

QT Imaging Announces Third Quarter 2024 Financial Results

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems (the “Company” or “QTI”) is pleased to announce an insiders private investment in public equities (PIPE) investment of $1.0 million in new funding, led by the Chairman of the Board, Dr. Avi Katz, and the Chief Executive Officer, Dr. Raluca Dinu, with participation of an additional four QTI Board of Directors m.

QT Imaging Holdings Announces $1M Insiders PIPE Investment

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the third year renewal of its five-year research grant from the National Institutes of Health (NIH)/National Cancer Institute (NCI). The study is a collaboration with the Department of Radiation Oncology, the Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toront.

QT Imaging Granted Renewal of NIH Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce an amendment to its $10,000,000 convertible promissory note with YA II PN, Ltd. (the “Investor,” and such promissory note, the “Note”). On September 11, 2024, a trigger event associated with the share price of the company occurred under the terms of the Note. As a result, the company m.

QT Imaging Holdings Announces Favorable Amendment of Convertible Promissory Note

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation in the International Ultrasonics Symposium (IUS), an IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society conference, held in Taipei, Taiwan, on September 22-26, 2024. Dr. James Wiskin will represent QTI in the Medical Imaging subsection. The presentation focuss.

QT Imaging Holdings Announces Participation in the IEEE International Ultrasonics Symposium, in Taipei, Taiwan

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce further expansion of locations offering the Breast Acoustic CT™ Scanner to Vitality Renewal Functional Medicine, in Crystal Lake, Illinois. The commercial shipment was made together with our strategic business and distribution partner. Dr. Yvonne Karney, founder of Vitality Renewal Func.

QT Imaging Holdings Announces Further Expansion of Locations Offering Its Technology at Vitality Renewal, in Illinois

QT Imaging Holdings (NASDAQ: QTI ) just reported results for the second quarter of 2024. QT Imaging Holdings reported earnings per share of -30 cents.

QTI Stock Earnings: QT Imaging Holdings Reported Results for Q2 2024

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. “QT Imaging's team completed the first full quarter in the life of our young public company. We continued to deliver against our plan for the engineering and clinical feasibility study to solidify the intended.

QT Imaging Announces Second Quarter 2024 Financial Results

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce our latest shipment of the Breast Acoustic CT™ Scanner to PerfeQTion Imaging Center in Haverford, Pennsylvania, together with our strategic business and distribution partner. Founded by Dr. Jennifer Simmons, an integrative oncologist, breast surgeon, and founder of functional medicine c.

QT Imaging Holdings Announces Partnership with PerfeQTion Imaging Center in Haverford, Pennsylvania

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment. University of Oklahoma (OU) is home to the National Cancer Institute (NCI) designated OU Health Steph.

QT Imaging Holdings' Technology Advances Medical Imaging Research at the University of Oklahoma's Health Stephenson Cancer Center

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first quarter of 2024. QT Imaging delivers today the QT Imaging Breast Acoustic CT™ Scanner, the only true 3D imaging device, FDA cleared for use as a transmission and reflection low frequency soundwaves imaging system for a patient's.

QT Imaging Announces First Quarter 2024 Financial Results

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) (“QT Imaging”) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with its strategic business and distribution partner, is proud to announce its partnership with The Vincere Cancer Center in Scottsdale, AZ. The Vincere Cancer Center is a top cancer center in the U.S. Founded by Dr. Vershalee Shukla and Dr. Pablo Prichard, the Center focuses on cancer.

QT Imaging Holdings Announces Partnership with Premier Cancer Center, The Vincere Cancer Center in Scottsdale, AZ

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is proud to announce the Opening Bell Ceremony at the Nasdaq MarketSite in Times Square. In honor of the occasion, Dr. Raluca Dinu, Chief Executive Officer, will ring the Opening Bell. Where: Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio When: Tuesday, April 23rd, 2024 – 9:15 a.

QT Imaging Holdings (Nasdaq: QTI) to Ring The Nasdaq Stock Market Opening Bell

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is proud to announce positive data regarding the diagnostic performance of QTI's Breast Acoustic CTTM Scans for mass detection from its second blinded multi-reader multi-case study. The study was published in Academic Radiology, online, in January 2024: A Multireader Multicase (MRMC) Receiver Operating Charact.

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with our strategic business and distribution partner are proud to announce their partnership with the Center of New Medicine in Irvine, California. The Center for New Medicine is one of the largest integrative medical clinics in North America, providing a personalized approach to health care includin.

QT Imaging's Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that the Board of Directors has appointed former GigCapital5, Inc. CEO Dr. Raluca Dinu as Active Chief Executive Officer and member of the Board of Directors, effective March 12, 2024. Dr. Dinu will serve in this position for one year, when the Company will reevaluate this strategic position.

QT Imaging Holdings names Dr. Raluca Dinu as Acting Chief Executive Officer and Anastas Budagov as Chief Financial Officer

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI), a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, updated the ticker symbol for its warrants to “QTIWW”, currently trading in the over-the-counter (OTC) market, effective as of March 11, 2024. The company's units formerly trading in the OTC market under “GIAFU” have been delisted as of March 11, 2024, as each unit was split into one share of common sto.

QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the delivery of a Breast Acoustic CT™ Scanner under a unique collaboration with the Department of Radiation Oncology, and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Canada, one of the largest cancer centers in Canada, and The University of Illinois,.

QT Imaging's Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the first commercial sale of a QTI Breast Acoustic CT™ System to True Health Center for Functional Medicine. QTI's inaugural customer was born as a result of the collaboration with our previously announced strategic distribution partner and represents the business model to be deployed b.

News for QT Imaging Holdings Inc Stock (QTI)